We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+10.86%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$31.6B
AUM Growth
+$198M
Cap. Flow
-$2.67B
Cap. Flow %
-8.44%
Top 10 Hldgs %
16.74%
Holding
613
New
72
Increased
154
Reduced
196
Closed
161

Sector Composition

Rank Sector Weight
1 Technology 25.09%
2 Financials 14.14%
3 Industrials 13.73%
4 Healthcare 11.66%
5 Consumer Discretionary 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
201
Union Pacific
UNP
$174B
$41.6M 0.13%
182,632
-167,390
-48% -$39.6M
LRN icon
202
Stride
LRN
$4.16B
$41.5M 0.13%
399,467
-246,957
-38% -$23.5M
ODFL icon
203
Old Dominion Freight Line
ODFL
$46.3B
$41.4M 0.13%
234,794
+95,725
+69% +$19.5M
MIR icon
204
Mirion Technologies
MIR
$3.63B
$41.3M 0.13%
2,368,734
+981,199
+71% +$15.2M
MOG.A icon
205
Moog Inc Class A
MOG.A
$12.4B
$40.2M 0.13%
204,096
+36,053
+21% +$7.4M
GLBE icon
206
Global E Online
GLBE
$6.76B
$40.1M 0.13%
+736,221
New +$33.3M
VITL icon
207
Vital Farms
VITL
$586M
$39.9M 0.13%
1,058,753
+415,614
+65% +$14.8M
TMO icon
208
Thermo Fisher Scientific
TMO
$214B
$38.9M 0.12%
74,781
-2,496
-3% -$1.37M
WST icon
209
West Pharmaceutical
WST
$23.7B
$38.7M 0.12%
118,276
+17,985
+18% +$5.66M
CORZ icon
210
Core Scientific
CORZ
$5.82B
$38.7M 0.12%
+2,755,914
New +$40.7M
ITGR icon
211
Integer Holdings
ITGR
$3.39B
$38.2M 0.12%
288,555
-1,565
-0.5% -$209K
BDX icon
212
Becton Dickinson
BDX
$46.4B
$37.9M 0.12%
167,261
-28,597
-15% -$6.6M
ADMA icon
213
ADMA Biologics
ADMA
$2.02B
$37.9M 0.12%
2,207,277
-887,180
-29% -$16.7M
PRIM icon
214
Primoris Services
PRIM
$4.06B
$37.5M 0.12%
490,356
+223,551
+84% +$16.3M
CMCO icon
215
Columbus McKinnon
CMCO
$422M
$37.1M 0.12%
995,830
-7,921
-0.8% -$288K
CRNX icon
216
Crinetics Pharmaceuticals
CRNX
$8.88B
$37M 0.12%
724,625
-21,493
-3% -$1.2M
MTSI icon
217
MACOM Technology Solutions
MTSI
$17.4B
$36.6M 0.12%
+281,715
New +$35.4M
TW icon
218
Tradeweb Markets
TW
$23B
$36.3M 0.11%
277,366
+195,975
+241% +$25.8M
CODI icon
219
Compass Diversified
CODI
$752M
$36M 0.11%
1,559,280
-78,323
-5% -$1.76M
LTH icon
220
Life Time Group Holdings
LTH
$10.2B
$35.6M 0.11%
1,610,549
+317,566
+25% +$7.59M
PG icon
221
Procter & Gamble
PG
$340B
$35.4M 0.11%
211,406
WTFC icon
222
Wintrust Financial
WTFC
$10.7B
$35.4M 0.11%
284,040
-2,301
-0.8% -$284K
CW icon
223
Curtiss-Wright
CW
$25.1B
$35.2M 0.11%
99,142
-823
-0.8% -$296K
DOCS icon
224
Doximity
DOCS
$3.89B
$34.9M 0.11%
654,563
-21,437
-3% -$1.05M
DECK icon
225
Deckers Outdoor
DECK
$14.1B
$34.8M 0.11%
171,579
+110,685
+182% +$20M

Similar funds

Lord, Abbett & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Lord, Abbett & Co held 613 positions worth $31.6B, up 0.63% from $31.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Lord, Abbett & Co withdrew a net $2.67B in Q4 2024, closing 161 positions and reducing 196 holdings. Its most notable exit was NextEra Energy, Inc. 6.926% Corporate Units, an estimated $193M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.

Against the trend, Lord, Abbett & Co opened a new position in Tesla worth $273M.

  • Lord, Abbett & Co's largest Q4 2024 buy was Tesla: 675,831 shares worth $273M.
  • Lord, Abbett & Co added most to Invesco Senior Loan ETF in Q4 2024, an estimated $134M increase.
  • Lord, Abbett & Co's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $193M.
  • Lord, Abbett & Co fully exited NextEra Energy, Inc. 6.926% Corporate Units in Q4 2024, selling an estimated $193M.
  • Lord, Abbett & Co's ten largest holdings make up 17% of its $31.6B portfolio in Q4 2024.
  • Lord, Abbett & Co opened 72 new positions and closed 161 in Q4 2024.
  • Lord, Abbett & Co's portfolio value rose 0.63% quarter-over-quarter to $31.6B.

Based on Lord, Abbett & Co's 13F filing for Q4 2024, filed 14 Feb 2025.